| abstract |
An isolated nucleic acid molecule comprising a polynucleotide selected from the group consisting of: (a) a polynucleotide encoding amino acids 1 to 273 of SEQ ID NO: 2; (b) a polynucleotide encoding amino acids 2 to 2 273 of SEQ ID NO: 2; (c) a polynucleotide encoding amino acids 26 through 273 of SEQ ID NO: 2; (d) the polynucleotide complement of the polynucleotide of (a), (b) or ( C); and (e) a polynucleotide at least 90% identical to the polynucleotide of (a), (b), (c), or (d) that is expressed differentially between breast cancer cells with high metastatic capacity and cancer cells non-metastatic or with low metastatic capacity. |